Eight Clusters Of Related Biomarkers Associated With RA-ILD, Study Finds

Healio (4/30, Cooper) reports a study found that “biomarkers in blood and plasma can be used to predict rheumatoid arthritis-associated interstitial lung disease more accurately than clinical risk factors alone, suggesting potential new opportunities in screening and treatment.” Researchers said their “process yielded a total of 15 principal components, or clusters of related biomarkers. After adjusting for clinical factors, eight were significantly associated with RA-ILD.” The study was published in Arthritis & Rheumatology.